Click for best price

Hereditary Cancer Testing Market Size, Share 2023

Market Analysis and Insights: Global Hereditary Cancer Testing Market

The global Hereditary Cancer Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hereditary Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hereditary Cancer Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hereditary Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hereditary Cancer Testing market.

Global Hereditary Cancer Testing Scope and Market Size

Hereditary Cancer Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.

Segment by Type

RNA Testing

DNA Testing

Segment by Application

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory/Lung Cancer

Other Cancers

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Ambry Genetics (Konica Minota)

Asper Biogene

Natera

Caris Life Sciences

BioReference Laboratories (GeneDx)

LabSolutions

Progenity?Inc

ARUP Laboratories

Myriad

NeoGenomics

Blueprint Genetics

CellMax Life

Fulgent Genetics

Strand Life Sciences

Myogenes

LabCorp

Quest Diagnostics

Pathway Genomics

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Hereditary Cancer Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Hereditary Cancer Testing, with price, sales, revenue, and global market share of Hereditary Cancer Testing from 2019 to 2022.

Chapter 3, the Hereditary Cancer Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hereditary Cancer Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Hereditary Cancer Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Cancer Testing.

Chapter 13, 14, and 15, to describe Hereditary Cancer Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Hereditary Cancer Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Hereditary Cancer Testing Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2022
Forecast Year	2030
Number of Pages	104 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2018-2032)
2.2 Hereditary Cancer Testing Growth Trends by Region
2.2.1 Hereditary Cancer Testing Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2018-2023)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2023-2032)
2.3 Hereditary Cancer Testing Market Dynamics
2.3.1 Hereditary Cancer Testing Industry Trends
2.3.2 Hereditary Cancer Testing Market Drivers
2.3.3 Hereditary Cancer Testing Market Challenges
2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Revenue
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2018-2023)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2022
3.5 Hereditary Cancer Testing Key Players Head office and Area Served
3.6 Key Players Hereditary Cancer Testing Product Solution and Service
3.7 Date of Enter into Hereditary Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2018-2023)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2032)
5 Hereditary Cancer Testing Breakdown Data by Application
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2018-2023)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2018-2032)
6.2 North America Hereditary Cancer Testing Market Size by Country (2018-2023)
6.3 North America Hereditary Cancer Testing Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2018-2032)
7.2 Europe Hereditary Cancer Testing Market Size by Country (2018-2023)
7.3 Europe Hereditary Cancer Testing Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2018-2032)
8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size (2018-2032)
9.2 Latin America Hereditary Cancer Testing Market Size by Country (2018-2023)
9.3 Latin America Hereditary Cancer Testing Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2018-2032)
10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Detail
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2018-2023)
11.1.5 Ambry Genetics (Konica Minota) Recent Development
11.2 Asper Biogene
11.2.1 Asper Biogene Company Detail
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2018-2023)
11.2.5 Asper Biogene Recent Development
11.3 Natera
11.3.1 Natera Company Detail
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2018-2023)
11.3.5 Natera Recent Development
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Detail
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2018-2023)
11.4.5 Caris Life Sciences Recent Development
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Detail
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2018-2023)
11.5.5 BioReference Laboratories (GeneDx) Recent Development
11.6 LabSolutions
11.6.1 LabSolutions Company Detail
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2018-2023)
11.6.5 LabSolutions Recent Development
11.7 Progenity?Inc
11.7.1 Progenity?Inc Company Detail
11.7.2 Progenity?Inc Business Overview
11.7.3 Progenity?Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity?Inc Revenue in Hereditary Cancer Testing Business (2018-2023)
11.7.5 Progenity?Inc Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Detail
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2018-2023)
11.8.5 ARUP Laboratories Recent Development
11.9 Myriad
11.9.1 Myriad Company Detail
11.9.2 Myriad Business Overview
11.9.3 Myriad Hereditary Cancer Testing Introduction
11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2018-2023)
11.9.5 Myriad Recent Development
11.10 NeoGenomics
11.10.1 NeoGenomics Company Detail
11.10.2 NeoGenomics Business Overview
11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2018-2023)
11.10.5 NeoGenomics Recent Development
11.11 Blueprint Genetics
11.11.1 Blueprint Genetics Company Detail
11.11.2 Blueprint Genetics Business Overview
11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2018-2023)
11.11.5 Blueprint Genetics Recent Development
11.12 CellMax Life
11.12.1 CellMax Life Company Detail
11.12.2 CellMax Life Business Overview
11.12.3 CellMax Life Hereditary Cancer Testing Introduction
11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2018-2023)
11.12.5 CellMax Life Recent Development
11.13 Fulgent Genetics
11.13.1 Fulgent Genetics Company Detail
11.13.2 Fulgent Genetics Business Overview
11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2018-2023)
11.13.5 Fulgent Genetics Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Detail
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2018-2023)
11.14.5 Strand Life Sciences Recent Development
11.15 Myogenes
11.15.1 Myogenes Company Detail
11.15.2 Myogenes Business Overview
11.15.3 Myogenes Hereditary Cancer Testing Introduction
11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2018-2023)
11.15.5 Myogenes Recent Development
11.16 LabCorp
11.16.1 LabCorp Company Detail
11.16.2 LabCorp Business Overview
11.16.3 LabCorp Hereditary Cancer Testing Introduction
11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2018-2023)
11.16.5 LabCorp Recent Development
11.17 Quest Diagnostics
11.17.1 Quest Diagnostics Company Detail
11.17.2 Quest Diagnostics Business Overview
11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2018-2023)
11.17.5 Quest Diagnostics Recent Development
11.18 Pathway Genomics
11.18.1 Pathway Genomics Company Detail
11.18.2 Pathway Genomics Business Overview
11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2018-2023)
11.18.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of RNA Testing
Table 3. Key Players of DNA Testing
Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Hereditary Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hereditary Cancer Testing Market Share by Region (2018-2023)
Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 9. Global Hereditary Cancer Testing Market Share by Region (2023-2032)
Table 10. Hereditary Cancer Testing Market Trends
Table 11. Hereditary Cancer Testing Market Drivers
Table 12. Hereditary Cancer Testing Market Challenges
Table 13. Hereditary Cancer Testing Market Restraints
Table 14. Global Hereditary Cancer Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hereditary Cancer Testing Market Share by Players (2018-2023)
Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2022)
Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
Table 21. Date of Enter into Hereditary Cancer Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hereditary Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2023-2032)
Table 27. Global Hereditary Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2018-2023)
Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2023-2032)
Table 31. North America Hereditary Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hereditary Cancer Testing Market Size by Country (2023-2032) & (US$ Million)
Table 33. Europe Hereditary Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Hereditary Cancer Testing Market Size by Country (2023-2032) & (US$ Million)
Table 35. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2023-2032) & (US$ Million)
Table 37. Latin America Hereditary Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Hereditary Cancer Testing Market Size by Country (2023-2032) & (US$ Million)
Table 39. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2032) & (US$ Million)
Table 41. Ambry Genetics (Konica Minota) Company Detail
Table 42. Ambry Genetics (Konica Minota) Business Overview
Table 43. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
Table 44. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 45. Ambry Genetics (Konica Minota) Recent Development
Table 46. Asper Biogene Company Detail
Table 47. Asper Biogene Business Overview
Table 48. Asper Biogene Hereditary Cancer Testing Product
Table 49. Asper Biogene Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 50. Asper Biogene Recent Development
Table 51. Natera Company Detail
Table 52. Natera Business Overview
Table 53. Natera Hereditary Cancer Testing Product
Table 54. Natera Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 55. Natera Recent Development
Table 56. Caris Life Sciences Company Detail
Table 57. Caris Life Sciences Business Overview
Table 58. Caris Life Sciences Hereditary Cancer Testing Product
Table 59. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 60. Caris Life Sciences Recent Development
Table 61. BioReference Laboratories (GeneDx) Company Detail
Table 62. BioReference Laboratories (GeneDx) Business Overview
Table 63. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
Table 64. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 65. BioReference Laboratories (GeneDx) Recent Development
Table 66. LabSolutions Company Detail
Table 67. LabSolutions Business Overview
Table 68. LabSolutions Hereditary Cancer Testing Product
Table 69. LabSolutions Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 70. LabSolutions Recent Development
Table 71. Progenity?Inc Company Detail
Table 72. Progenity?Inc Business Overview
Table 73. Progenity?Inc Hereditary Cancer Testing Product
Table 74. Progenity?Inc Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 75. Progenity?Inc Recent Development
Table 76. ARUP Laboratories Company Detail
Table 77. ARUP Laboratories Business Overview
Table 78. ARUP Laboratories Hereditary Cancer Testing Product
Table 79. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 80. ARUP Laboratories Recent Development
Table 81. Myriad Company Detail
Table 82. Myriad Business Overview
Table 83. Myriad Hereditary Cancer Testing Product
Table 84. Myriad Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 85. Myriad Recent Development
Table 86. NeoGenomics Company Detail
Table 87. NeoGenomics Business Overview
Table 88. NeoGenomics Hereditary Cancer Testing Product
Table 89. NeoGenomics Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 90. NeoGenomics Recent Development
Table 91. Blueprint Genetics Company Detail
Table 92. Blueprint Genetics Business Overview
Table 93. Blueprint Genetics Hereditary Cancer TestingProduct
Table 94. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 95. Blueprint Genetics Recent Development
Table 96. CellMax Life Company Detail
Table 97. CellMax Life Business Overview
Table 98. CellMax Life Hereditary Cancer TestingProduct
Table 99. CellMax Life Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 100. CellMax Life Recent Development
Table 101. Fulgent Genetics Company Detail
Table 102. Fulgent Genetics Business Overview
Table 103. Fulgent Genetics Hereditary Cancer TestingProduct
Table 104. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 105. Fulgent Genetics Recent Development
Table 106. Strand Life Sciences Company Detail
Table 107. Strand Life Sciences Business Overview
Table 108. Strand Life Sciences Hereditary Cancer TestingProduct
Table 109. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 110. Strand Life Sciences Recent Development
Table 111. Myogenes Company Detail
Table 112. Myogenes Business Overview
Table 113. Myogenes Hereditary Cancer TestingProduct
Table 114. Myogenes Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 115. Myogenes Recent Development
Table 116. LabCorp Company Detail
Table 117. LabCorp Business Overview
Table 118. LabCorp Hereditary Cancer TestingProduct
Table 119. LabCorp Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 120. LabCorp Recent Development
Table 121. Quest Diagnostics Company Detail
Table 122. Quest Diagnostics Business Overview
Table 123. Quest Diagnostics Hereditary Cancer TestingProduct
Table 124. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 125. Quest Diagnostics Recent Development
Table 126. Pathway Genomics Company Detail
Table 127. Pathway Genomics Business Overview
Table 128. Pathway Genomics Hereditary Cancer TestingProduct
Table 129. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2018-2023) & (US$ Million)
Table 130. Pathway Genomics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2022 VS 2032
Figure 2. RNA Testing Features
Figure 3. DNA Testing Features
Figure 4. Global Hereditary Cancer Testing Market Share by Application in 2022 & 2032
Figure 5. Breast Cancer Case Studies
Figure 6. Gastrointestinal Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Respiratory/Lung Cancer Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Hereditary Cancer Testing Report Years Considered
Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 12. Global Hereditary Cancer Testing Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 13. Global Hereditary Cancer Testing Market Share by Region: 2022 VS 2032
Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2022
Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2022
Figure 17. North America Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 18. North America Hereditary Cancer Testing Market Share by Country (2018-2032)
Figure 19. United States Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Canada Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Hereditary Cancer Testing Market Share by Country (2018-2032)
Figure 23. Germany Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. France Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. U.K. Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Italy Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Russia Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2018-2032)
Figure 31. China Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Japan Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. South Korea Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. India Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Australia Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Hereditary Cancer Testing Market Share by Country (2018-2032)
Figure 39. Mexico Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Brazil Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2018-2032)
Figure 43. Turkey Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 46. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 47. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 48. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 49. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 50. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 51. Progenity?Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 52. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 53. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 54. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 55. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 56. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 57. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 58. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 59. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 60. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 61. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 62. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Hereditary Cancer Testing Market Research Report 2023